- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07938736
Quality of Life, Decision-making, Resilience, Satisfaction and Success Rate of Different IVF Treatment Strategies: an International Prospective Cohort Study
Study aims to assess the quality of life and mental health of patients suffering from infertility. Secondly, this study aims to discover the true reasons for choosing a certain IVF treatment (whether quality of life related or otherwise) and the extent to which defined factors (e.g. cost, doctor recommendations, stress levels and effectiveness) influence this choice. Thirdly, the study aims to examine psychological resilience in adhering to a treatment choice and the reasons for changing treatment. Finally, we will evaluate the cumulative live birth rate over a planned timeframe, including that experienced with IVF Naturelle, as these are currently unknown.
Studie Overzicht
Toestand
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Michael von Wolff, Professor
- Telefoonnummer: 0041 31 632 13 01
- E-mail: michael.vonwolff@insel.ch
Studie Locaties
-
-
Canton of Bern
-
Bern, Canton of Bern, Zwitserland, 3000
- Werving
- Frauenklinik Bern, Universitätspital Inselspital Bern
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
The project population consists IVF patients who are willing to participate in this study. Patients should not have had an IVF treatment before or, if a clinical pregnancy had been achieved by IVF, a new IVF therapy should not have started since then.
After receiving advice on the advantages and disadvantages of each type of in vitro fertilisation treatment (NC/ Min-stim IVF and cIVF strategy), couples will be free to decide which IVF treatment strategy they wish to follow. Couple are also free to change treatment strategy during the 6 month treatment phase.
Beschrijving
Inclusion Criteria:
- Female patient age ≥ 18 till 44
- Indication for IVF/ICSI
- First IVF treatment or first IVF treatment after a clinical pregnancy (spontaneous conception or pregnancy achieved by IVF)
- Cycles with intended fresh and/or frozen ETs within 6 months (= study period)
- In case of NC-IVF: regular menstrual cycle (Eumenorrhae = 24-38 day of cycle)
Exclusion Criteria:
- IVF cycle with PGT for monogenetic diseases
- cIVF cycles with PGT for aneuploidy without the intention to have an embryo transfer within 6 months
- Social freezing cycles
- Medical freezing cycles
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Cohorten en interventies
Groep / Cohort |
|---|
|
Group 1
NC-/Min Stim IVF |
|
Group 2
cIVF |
|
Group 3/Mixed IVF Group
NC-/Min Stim IVF and cIVF |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Quality of life
Tijdsspanne: 6 months
|
Quality of life related to infertility will be analyzed using the Fertility Quality of Life (FertiQoL) questionnaire. The FertiQoL questionnaire contains 36 items in total, assessing the personal and interpersonal impact, quality of life specifically related to medical interventions, and general self-rated health and quality of life. Scores on the response scales are reversed, summed and scaled to range from 0 to 100. Higher scores on the subscales and total scores indicate better quality of life. |
6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Mental Health
Tijdsspanne: 6 months
|
Mental health related to infertility will be analyzed using the Center for Epidemiologic Studies Depression Scale (CES-D) scale. The standard CES-D is a 20-item self-report questionnaire assessing depressive symptoms experienced over the past week. Scores range between 0 to 60. Higher scores indicate greater severity and frequency of depressive symptoms. |
6 months
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Factors first choice of IVF
Tijdsspanne: 6 months
|
Which factors have affected your first choice of IVF treatment strategy? |
6 months
|
|
Success rate
Tijdsspanne: 6 months
|
Number of pregnancies (clinical/ongoing), any live birth (defined as at least one delivery of a live infant resulting from all NC/Min stim-IVF, cIVF or mixed treatment cycles, inclusive frozen embryo transfer (FET) cycles until pregnancy occurred or until 6 months were over). Type of IVF (in each cycle): NC-, Min stim- and cIVF Number of miscarriages Number of ectopic pregnancies, others outcome of pregnancy Number of women who discontinue IVF treatment Premature ovulation: yes/no Number of oocytes, zygotes, embryos and frozen embryos (inclusive day of freezing) Preimplantation Genetic Testing (PGT) (yes or no) Technology of fertilization (IVF or ICSI or both) Day of embryo transfer (2, 3 or 5) Number of transferred embryos Number of frozen embryos remaining at the end of the six-month observation period (inclusive day of freezing) |
6 months
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PRO-IVF Study
- DLF-Nr: 6269 (Andere identificatie: Department für Lehre und Forschung)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .